SMTL ID : 6t9s.1

Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.70 Å
Oligo State
monomer
Ligands
2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(5-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x GOL: GLYCEROL(Non-functional Binders)
3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x MXK: (2~{E})-2-hydroxyimino-~{N}-[(1~{S})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]ethanamid e(Non-covalent)
2 x SO4: SULFATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Marakovic, N. et al., Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases. Biochem.J. (2020)
Release Date
2020-07-15
Peptides
Cholinesterase: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Cholinesterase

Related Entries With Identical Sequence

1p0i.1 | 1p0i.2 | 1p0i.3 | 1p0m.1 | 1p0p.1 | 1p0p.2 | 1p0q.1 | 1xlu.1 | 1xlu.2 | 1xlv.1 | 1xlv.2 | 1xlw.1 | 1xlw.2 | 2wsl.1 | 3djy.1 | 3djy.2 | 3dkk.1 | 3dkk.2 | 4bds.1 | 6ep4.1 | 6eqp.1 | 6eqq.1 | 6i0b.1 | 6i0c.1 | 6sam.1 | 6t9p.1 | 6t9p.2 | 6xta.1 | 6zwi.1 | 7amz.1  more...